• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Technoderma Completes Ph2a Proof-Of-Concept For TDM-180935

    PR NEWSWIRE

    TechnodermaAdvances TDM-180935 to Phase 2 in Atopic Dermatitis

    PR NEWSWIRE

    Technoderma Phase 2 of TDM-105795 Shows Hair Growth in Androgenetic Alopecia

    PR NEWSWIRE

    Technoderma Completes Phase 1 Dose Escalation Clinical Trial of TDM-180935

    PR NEWSWIRE

    Technoderma Medicines Initiates TDM-105795 Androgenetic Alopecia Ph2 Trial

    PR NEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.